A new study found that an “often-overlooked” parasitic infection, already linked to bladder cancer, could also trigger cancer-related gene activity in the cervical lining. Even more troubling ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant ...

The first new type of oral antibiotic for uncomplicated urinary tract infections in almost three decades was approved by the US Food and Drug Administration, a boost for GSK Plc in an area largely ...

US and MCUG for all children aged <2 years. 99m Tc–DMSA scan in high-grade reflux [3] Urinary tract infection (UTI) is the most common serious bacterial infection in childhood, and its ...

Urinary tract infections (UTIs) are the most common infectious problem among older adults both in the community and institutional settings. With the expected increase in this population ...

Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of non-invasive assessments work just as well in guiding treatment. Led by ...

TUESDAY, March 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult ...

March 26, 2025 — The FDA has approved a new medication to treat uncomplicated urinary tract infections in women and girls aged 12 or older. It is the first in a new class of oral antibiotics ...

The Food and Drug Administration on Tuesday approved the first drug in a new class of antibiotics for treating urinary tract infections — the first time that’s happened in nearly 30 years.

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...